Extended-release monthly buprenorphine injection.

Ari B Cuperfain,Tianna Costa,Nitin Chopra

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne（2023）

引用 0|浏览7

暂无评分

摘要

In 2018, Health Canada approved the only BUP-XR treatment available in Canada, under the brand name Sublocade. It is covered by all provinces and territories as part of their public drug plans, primarily for treating moderate-to-severe opioid use disorder. All prescribers across Canada must complete

查看译文

关键词

extended-release

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要